Clinical evaluation of a novel method for the measurement of prostate‐specific antigen, AccuPSATM, as a predictor of 5‐year biochemical recurrence‐free survival after radical prostatectomy: results of a pilot study

Clinical evaluation of a novel method for the measurement of prostate‐specific antigen, AccuPSATM, as a predictor of 5‐year biochemical recurrence‐free survival after radical prostatectomy: results of a pilot study

Study Type – Diagnostic (validating cohort) Level of Evidence 1b What's known on the subject? and What does the study add? Nadir Ultrasensitive PSA levels has some value for predicting BCR following RD. AccuPSA assays lower limit of PSA quantification of

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJU international 2012-06, Vol.109 (12), p.1770-1775
Hauptverfasser: Lepor, Herbert, Cheli, Carol D., Thiel, Robert P., Taneja, Samir S., Laze, Juliana, Chan, Dan W., Sokoll, Lori J., Mangold, Leslie, Partin, Alan W.
Format: Artikel
Sprache:eng
Schlagworte:
biochemical recurrence
Men
Methods
Prostate cancer
PSA
radical prostatectomy
Studies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Study Type – Diagnostic (validating cohort) Level of Evidence 1b What's known on the subject? and What does the study add? Nadir Ultrasensitive PSA levels has some value for predicting BCR following RD. AccuPSA assays lower limit of PSA quantification of
ISSN:1464-4096
1464-410X
DOI:10.1111/j.1464-410X.2011.10568.x